Sino Biopharmaceutical (SBMFF) News Today $0.95 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock SBMFF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Sino Biopharmaceutical Schedules Board Meeting for Interim Results and Dividend ConsiderationAugust 1 at 9:54 AM | msn.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 12-Month High - Here's What HappenedJuly 31 at 3:26 PM | marketbeat.comSino Biopharmaceutical Advances TQB6411 in Phase I Clinical TrialsJuly 22, 2025 | tipranks.comSino Biopharmaceutical Expands with LaNova Medicines Acquisition UpdateJuly 22, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Shares Gap Down - Should You Sell?July 21, 2025 | marketbeat.comSino Biopharmaceutical (OTCMKTS:SBMFF) Shares Up 23.8% - Still a Buy?July 18, 2025 | marketbeat.comSino Biopharmaceutical (OTCMKTS:SBMFF) Hits New 1-Year High - Still a Buy?July 17, 2025 | marketbeat.comSino Biopharmaceutical to acquire LaNova Medicines for up to $951 millionJuly 16, 2025 | msn.comSino Biopharmaceutical Acquires Full Stake in LaNova MedicinesJuly 15, 2025 | tipranks.comSino Biopharmaceutical’s New Breast Cancer Treatment Gains Regulatory AcceptanceJuly 10, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sees Large Volume Increase - Time to Buy?July 2, 2025 | marketbeat.comSino Biopharmaceutical Ltd (1177) - Investing.com UKJuly 1, 2025 | uk.investing.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading 8.7% Higher - Still a Buy?June 23, 2025 | marketbeat.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sees Large Decline in Short InterestJune 18, 2025 | marketbeat.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 4.4% - Should You Sell?June 17, 2025 | marketbeat.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 12-Month High - Time to Buy?June 10, 2025 | marketbeat.comSino Biopharmaceutical Secures Shareholder Approval for Key Resolutions at AGMJune 10, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 12-Month High - Still a Buy?June 4, 2025 | marketbeat.comSino Biopharmaceutical’s Phase III Study Shows Promising Results for NSCLC TreatmentJune 3, 2025 | tipranks.comSBMFF Sino Biopharmaceutical LimitedMay 29, 2025 | seekingalpha.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 52-Week High - Should You Buy?May 29, 2025 | marketbeat.comSino Biopharmaceutical’s TQB2868 Shows Promise in Pancreatic Cancer TreatmentMay 29, 2025 | tipranks.comSino Biopharmaceutical Unveils Promising Phase I Data for TQB2102 at ASCO 2025May 27, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading 5.3% Higher - Time to Buy?May 14, 2025 | marketbeat.comGlobal First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain TrialMay 6, 2025 | msn.comU.S. FDA Approves China-Produced Cancer DrugApril 28, 2025 | forbes.comSino Biopharmaceutical’s Penpulimab Injection Gains US FDA ApprovalApril 25, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Hits New 52-Week High - Here's What HappenedApril 24, 2025 | marketbeat.comSino Biopharmaceutical to Showcase 45 Research Results at 2025 ASCO MeetingApril 24, 2025 | tipranks.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Down 79.5% in MarchApril 16, 2025 | marketbeat.comSino Biopharmaceutical’s TQB3019 Approved for Clinical TrialsApril 9, 2025 | tipranks.comSino Biopharmaceutical Receives Approval for Clinical Trial of New Cancer DrugApril 3, 2025 | tipranks.comSino Biopharmaceutical’s TQB6411 Clinical Trial Application AcceptedApril 3, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading 4.9% Higher - Still a Buy?March 25, 2025 | marketbeat.comSino Biopharmaceutical Reports Positive Phase III Results for Breast Cancer TreatmentMarch 24, 2025 | tipranks.comAsian Market Insights: Sino Biopharmaceutical And 2 Other Prominent Penny StocksMarch 20, 2025 | finance.yahoo.comSino Biopharmaceutical Partners with Sciwind for Innovative RSV TreatmentFebruary 27, 2025 | tipranks.comDiscovering Value: 3 Penny Stocks With At Least US$700M Market CapFebruary 19, 2025 | finance.yahoo.comSino Biopharmaceutical Gains Approval for Innovative Tulobuterol PatchFebruary 6, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 12.3% - Here's What HappenedJanuary 30, 2025 | marketbeat.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Up 20.6% in DecemberDecember 29, 2024 | marketbeat.com3 Promising Penny Stocks With Market Caps Under US$11BDecember 23, 2024 | finance.yahoo.comSino Biopharmaceutical’s Promising Liver Cancer Treatment AdvancementNovember 21, 2024 | markets.businessinsider.comSino Biopharm Invests in LaNova for Cancer InnovationsNovember 20, 2024 | markets.businessinsider.comSino Biopharmaceutical’s Strategic Investment in BiotechNovember 17, 2024 | msn.comSino Biopharmaceutical Gains FDA Approval for New Cancer DrugNovember 15, 2024 | markets.businessinsider.comSino Biopharm’s Garsorasib Gains Approval in ChinaNovember 11, 2024 | markets.businessinsider.comSino Biopharmaceutical Sees Strong Q3 Financial GrowthNovember 1, 2024 | markets.businessinsider.comSino Biopharmaceutical to Boost Market Share through Strategic AcquisitionsOctober 31, 2024 | markets.businessinsider.comSino Biopharmaceutical (SBMFF) Receives a Buy from JefferiesOctober 27, 2024 | markets.businessinsider.com Get Sino Biopharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter. Email Address SBMFF Media Mentions By Week SBMFF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SBMFF News Sentiment▼0.600.48▲Average Medical News Sentiment SBMFF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SBMFF Articles This Week▼21▲SBMFF Articles Average Week Get Sino Biopharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies REGN News Today ALNY News Today ARGX News Today BNTX News Today RPRX News Today INSM News Today BIIB News Today ILMN News Today INCY News Today GNMSF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SBMFF) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sino Biopharmaceutical Please log in to your account or sign up in order to add this asset to your watchlist. Share Sino Biopharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SBMFF Stock Alerts